Jazz Pharmaceuticals PLC
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| 21.1 | 17.1 | 22.1 | 24.1 | 24.1 | 16.9 | 20.7 | 24.4 | 20.0 | 16.8 | 17.1 | 12.5 | 12.1 | 16.3 | 19.9 | 46.2 | 44.8 | 39.6 | 18.5 | 262.9 | – | – | – | – | – | – | – | – | 114.3 | 20.7 | 22.8 | 18.8 | 15.2 | 13.5 | 15.7 | – | – | – | 423.8 | 17.8 | |
| 5.2 | 4.5 | 5.8 | 6.2 | 5.7 | 5.1 | 5.5 | 5.9 | 5.6 | 4.0 | 4.2 | 4.1 | 3.6 | 4.0 | 2.5 | 2.8 | 3.5 | 4.0 | 3.9 | 4.0 | 2.8 | 2.5 | 3.0 | 2.8 | 2.3 | 2.7 | 2.9 | 2.4 | 2.4 | 2.2 | 2.0 | 1.9 | 1.8 | 1.9 | 1.9 | 1.6 | 2.0 | 2.4 | 2.8 | 3.6 | |
| 4.4 | 3.5 | 4.5 | 4.3 | 3.6 | 3.0 | 3.3 | 3.7 | 3.4 | 2.7 | 3.0 | 2.7 | 2.4 | 2.7 | 2.0 | 2.0 | 2.4 | 2.6 | 2.5 | 2.6 | 2.0 | 2.0 | 2.7 | 3.1 | 3.0 | 3.3 | 3.2 | 2.6 | 2.6 | 2.3 | 2.0 | 2.0 | 1.7 | 1.9 | 1.8 | 1.8 | 2.1 | 2.4 | 2.8 | 3.5 | |
| 6.5 | 5.6 | 6.8 | 7.1 | 6.5 | 5.8 | 6.1 | 6.5 | 6.2 | 4.6 | 4.8 | 4.6 | 4.0 | 4.4 | 3.0 | 3.4 | 4.1 | 4.4 | 3.9 | 6.3 | 4.8 | 4.3 | 4.6 | 4.4 | 3.7 | 4.1 | 4.1 | 3.6 | 3.6 | 3.4 | 3.1 | 3.0 | 2.7 | 2.8 | 2.7 | 2.6 | 2.9 | 3.4 | 3.6 | 4.2 | |
| 12.8 | 11.1 | 13.7 | 14.5 | 13.2 | 12.1 | 13.7 | 14.3 | 13.6 | 9.4 | 9.0 | 8.7 | 7.7 | 9.4 | 6.6 | 7.7 | 9.4 | 10.1 | 9.1 | 18.8 | 17.3 | 13.0 | 13.6 | 11.1 | 9.0 | 12.4 | 12.7 | 11.3 | 11.0 | 9.7 | 9.3 | 8.9 | 7.7 | 7.8 | 8.4 | 23.9 | 47.6 | 48.9 | 22.9 | 11.9 | |
| 21.7 | 16.3 | 20.3 | 16.4 | 15.7 | 14.2 | 16.1 | 20.2 | 16.4 | 11.2 | 12.8 | 12.0 | 10.0 | 14.4 | 11.0 | 12.9 | 17.2 | 16.7 | 12.1 | 14.0 | 10.7 | 10.7 | 15.8 | 11.3 | 7.9 | 11.9 | 10.9 | 9.2 | 10.6 | 8.0 | 7.4 | 7.1 | 6.2 | 5.6 | 5.1 | 5.1 | 6.1 | 8.3 | 10.0 | 10.8 | |
| 4.6% | 6.1% | 4.9% | 6.1% | 6.4% | 7.0% | 6.2% | 5.0% | 6.1% | 8.9% | 7.8% | 8.3% | 10.0% | 6.9% | 9.1% | 7.8% | 5.8% | 6.0% | 8.3% | 7.1% | 9.4% | 9.4% | 6.3% | 8.9% | 12.6% | 8.4% | 9.2% | 10.8% | 9.4% | 12.5% | 13.4% | 14.1% | 16.1% | 17.9% | 19.7% | 19.5% | 16.5% | 12.0% | 10.0% | 9.2% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 93.3% | 92.9% | 93.0% | 92.8% | 92.5% | 93.2% | 92.9% | 93.0% | 93.5% | 93.6% | 93.8% | 94.3% | 94.2% | 94.1% | 94.4% | 94.4% | 94.1% | 93.7% | 93.4% | 90.4% | 87.6% | 85.8% | 84.4% | 85.0% | 85.8% | 85.2% | 85.2% | 86.0% | 86.9% | 84.7% | 85.6% | 85.5% | 85.6% | 89.0% | 88.8% | 88.7% | 85.4% | 88.2% | 84.1% | 84.7% | |
| 37.2% | 39.8% | 39.7% | 39.1% | 35.0% | 32.7% | 28.5% | 26.1% | 30.8% | 32.5% | 33.8% | 35.8% | 31.9% | 24.6% | 9.5% | 9.1% | 11.7% | 16.0% | 30.0% | 17.6% | 10.3% | 5.5% | 2.9% | 7.2% | 6.9% | 8.5% | 9.3% | 11.2% | 15.0% | 17.2% | 15.6% | 16.4% | 18.2% | 17.6% | 14.6% | -7.1% | -11.9% | 5.3% | 11.1% | 31.1% | |
| 24.8% | 26.2% | 26.3% | 25.7% | 23.6% | 30.1% | 26.5% | 24.2% | 28.1% | 23.6% | 24.9% | 33.0% | 29.6% | 24.2% | 12.8% | 6.0% | 7.9% | 10.1% | 21.3% | 1.5% | -5.6% | -10.7% | -13.6% | -1.5% | -0.5% | -6.1% | -4.2% | -2.3% | 2.1% | 10.8% | 8.6% | 10.1% | 11.6% | 13.8% | 11.9% | -9.9% | -8.9% | -8.3% | 0.7% | 20.4% | |
| 24.2% | 27.5% | 28.6% | 37.9% | 36.2% | 35.8% | 34.0% | 29.3% | 34.4% | 35.3% | 33.3% | 34.3% | 35.6% | 27.5% | 23.2% | 21.6% | 20.4% | 24.0% | 32.7% | 28.7% | 26.1% | 23.7% | 18.8% | 25.2% | 29.4% | 23.0% | 26.4% | 26.3% | 22.9% | 27.9% | 26.3% | 26.7% | 28.3% | 33.4% | 36.6% | 31.0% | 32.1% | 29.2% | 28.1% | 33.5% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| 20.7% | 20.7% | 20.2% | 18.0% | 15.1% | 18.0% | 16.1% | 15.1% | 17.2% | 16.2% | 17.8% | 22.0% | 19.9% | 16.8% | 10.0% | 4.2% | 5.3% | 6.5% | 13.6% | 1.0% | -4.1% | -8.3% | -12.5% | -1.6% | -0.7% | -7.2% | -4.7% | -2.4% | 2.3% | 11.1% | 8.9% | 10.5% | 11.1% | 13.7% | 11.5% | -10.9% | -9.3% | -8.2% | 0.7% | 19.6% | |
| 7.2% | 8.1% | 8.3% | 8.2% | 7.4% | 9.5% | 8.5% | 8.1% | 9.5% | 8.6% | 9.2% | 11.9% | 11.0% | 9.4% | 5.4% | 2.2% | 2.8% | 3.7% | 7.7% | 0.3% | -1.3% | -2.7% | -3.8% | -0.5% | -0.2% | -2.1% | -1.4% | -0.8% | 0.7% | 3.6% | 2.9% | 3.5% | 3.8% | 4.7% | 4.2% | -3.7% | -3.2% | -3.1% | 0.2% | 8.5% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| 1,817 | 1,664 | 1,529 | 1,433 | 1,327 | 1,195 | 1,129 | 1,107 | 1,095 | 1,287 | 1,060 | 972 | 821 | 983 | 921 | 1,330 | 1,359 | 1,052 | 18 | 5,867 | 5,624 | 5,474 | 5,549 | 5,325 | 4,902 | 4,843 | 4,570 | 4,452 | 4,396 | 4,526 | 4,285 | 4,368 | 3,913 | 3,711 | 3,519 | 4,188 | 4,139 | 3,981 | 3,525 | 2,746 | |
| 2.5 | 2.2 | 2.0 | 1.9 | 1.7 | 1.5 | 1.5 | 1.4 | 1.3 | 1.4 | 1.0 | 0.9 | 0.8 | 1.0 | 0.9 | 1.4 | 1.4 | 1.0 | 0.0 | 6.7 | 7.1 | 5.3 | 4.9 | 3.9 | 3.3 | 4.0 | 3.8 | 3.7 | 3.5 | 3.3 | 3.4 | 3.3 | 2.8 | 2.6 | 2.7 | 9.4 | 16.1 | 13.6 | 5.0 | 1.7 | |
| 34.8% | 39.1% | 41.2% | 45.8% | 49.4% | 53.0% | 52.7% | 53.7% | 55.2% | 53.0% | 51.7% | 54.4% | 55.3% | 56.2% | 53.9% | 51.8% | 53.7% | 56.0% | 56.2% | 31.3% | 31.6% | 32.2% | 30.7% | 28.6% | 26.4% | 28.5% | 30.2% | 31.3% | 31.1% | 32.8% | 32.6% | 33.1% | 34.0% | 34.1% | 36.2% | 33.9% | 34.9% | 37.0% | 38.2% | 43.3% | |
| 1.3 | 1.1 | 0.9 | 0.8 | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | 0.6 | 0.7 | 0.6 | 0.6 | 0.6 | 1.6 | 1.6 | 1.5 | 1.7 | 1.9 | 2.1 | 1.9 | 1.7 | 1.6 | 1.6 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.3 | 1.5 | 1.4 | 1.2 | 1.2 | 0.9 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| 5.75 | 6.38 | 6.56 | 6.44 | 6.06 | 7.97 | 7.31 | 7.06 | 8.40 | 7.40 | 8.37 | 11.42 | 10.60 | 9.14 | 5.01 | 2.39 | 3.19 | 4.17 | 8.88 | 0.68 | -2.63 | -5.36 | -7.15 | -0.82 | -0.30 | -3.54 | -2.11 | -1.17 | 1.13 | 5.95 | 5.29 | 5.67 | 7.33 | 9.11 | 7.91 | -6.62 | -5.98 | -5.84 | 0.45 | 13.56 | |
| 23.18 | 24.38 | 24.98 | 25.08 | 25.70 | 26.45 | 27.58 | 29.19 | 29.92 | 31.30 | 33.65 | 34.62 | 35.80 | 37.75 | 39.11 | 39.68 | 40.54 | 41.34 | 41.72 | 44.17 | 46.72 | 50.31 | 52.46 | 54.89 | 57.08 | 58.04 | 50.68 | 51.17 | 53.22 | 55.03 | 61.46 | 56.16 | 63.20 | 66.16 | 66.66 | 66.78 | 67.49 | 69.98 | 67.15 | 66.30 | |
| 27.77 | 30.76 | 32.43 | 35.81 | 40.19 | 44.34 | 45.55 | 46.71 | 48.94 | 45.64 | 47.01 | 51.95 | 53.18 | 54.33 | 50.19 | 56.24 | 60.05 | 64.01 | 65.04 | 69.50 | 64.27 | 64.47 | 57.36 | 50.46 | 43.72 | 48.94 | 45.21 | 47.94 | 48.94 | 53.64 | 59.11 | 54.04 | 66.03 | 66.56 | 68.46 | 60.57 | 64.26 | 70.81 | 68.57 | 69.19 | |
| 5.60 | 6.70 | 7.15 | 9.51 | 9.29 | 9.46 | 9.37 | 8.54 | 10.28 | 11.05 | 11.20 | 11.86 | 12.75 | 10.37 | 9.09 | 8.56 | 8.27 | 9.91 | 13.64 | 12.68 | 12.19 | 11.92 | 9.88 | 13.84 | 16.77 | 13.37 | 13.39 | 13.44 | 12.18 | 15.33 | 16.17 | 15.00 | 17.88 | 22.08 | 24.41 | 20.67 | 21.69 | 20.46 | 18.84 | 22.22 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.